Paclitaxel is a chemotherapeutic drug with good antitumor effect in clinic. However, its poor water solubility and some serious toxic effects greatly limit the wide clinical application of paclitaxel. The emergence of a series of new dosage forms such as liposomes, micelles, microspheres and nanoparticles provides hope to break these restrictions.













